Table 4.
Biomarkers in HFrEF and HFpEF.
| - | HFrEF | - | HFpEF | |||
| - | Diagnosis | Exacerbation | Prognosis | Diagnosis | Exacerbation | Prognosis |
| NT-proBNP | High | High | High mortality | High to normal | High | Unknown |
| Galectin-3 | High | High | High mortality | High | High | High mortality |
| ST2 | High | High | High mortality | High | High | High mortality (compered to Pro-BNP) |
| HS-Troponin | High | High | High mortality | High | High | Unknown |
| Hs-CRP | High | High | Unknown | High (compered to Pro-BNP) | High (compered to Pro-BNP) | Unknown |
| Neurolipin | High | High | Unknown | High (compered to Pro-BNP) | High (compered to Pro-BNP) | Unknown |
Abbreviations: HFrEF -Heart failure with reduced ejection fraction, HFpEF—Heart failure with preserved ejection fraction.